Home >> Marketplace Directory >> FDA clearance for parathyroid hormone assay, 7/14

FDA clearance for parathyroid hormone assay, 7/14

image_pdfCreate PDF

July 2014—DiaSorin received FDA clearance for its Liaison N-Tact PTH Gen II immunoassay, intended for the quantitative determination of intact human parathyroid hormone in human serum and plasma samples. The kit contains 200 tests and has an open-kit shelf life of 8 weeks, meeting the needs of small- and large-volume laboratories. It also has low cross-reactivity to the 7-84 and other inactive fragments, supporting conservative patient management.

DiaSorin, 651-351-5701

CAP TODAY
X